Rapport Therapeutics, Inc.
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
RAPP | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 99 HIGH STREET, 2110 BOSTON
- Website:
- https://www.rapportrx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Rapport Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing a portfolio of precision small molecule medicines for patients with Central Nervous System (CNS) disorders. The company's approach is centered on precision neuromedicine, aiming to create therapies with neuroanatomically precise targeting to achieve transformational outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Rapport Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Rapport Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Rapport Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
